Canaccord’s healthcare analyst Corey Davis weighed in with a few insights on Pacira Pharmaceuticals Inc (NASDAQ:PCRX), after the company announced that it is suing the …
Recently, various executives have taken part in insider selling activity for the stocks of Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Kite Pharma Inc (NASDAQ:KITE), Agios Pharmaceuticals Inc (NASDAQ:AGIO), and Pacira …
In a research report released Wednesday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX) with a price …
Shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX) took it on the chin at Thursday’s open as the company completely removed sales guidance for its only marketed …
Out of all of the stocks in the Healthcare sector, biopharmaceutical stocks are some of the most popular due to the revenue potential …
In a research note issued today, Wedbush analyst Liana Moussatos (TipRanks #1) reiterated an Outperform rating on Pacira (NASDAQ:PCRX) and slightly raised her price …
Brean Capital analyst Jonathan Aschoff assigned a Buy rating on Pacira (NASDAQ:PCRX) with a price target of $111, following the company’s third quarter …
In a research report released yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Pacira Pharmaceuticals (NASDAQ:PCRX) with a $117 price target, following Moussatos’s …
In a research report published today, analyst Jonathan Aschoff of Brean Capital maintained a Buy rating on Pacira (NASDAQ:PCRX) with a $111 price target, which represents a …
In a report issued today, analyst Liana Moussatos of Wedbush reiterated an Outperform rating on Pacira Pharmaceuticals (NASDAQ:PCRX) with a $117 price target, as the company recently announced …
